Location Durham, North Carolina, United States Regions Research Triangle, East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
Joe is the President and CEO of Bioventure Partners, a growth advisory and investment firm, serving high-impact, technology driven organizations. Previously, Joe was with KBI Biopharma, a biopharmaceutical CDMO from 2002 until 2016, having served as its President and CEO. During this period, KBI grew from a startup to a 500+ person organization,
serving over 300 biopharmaceutical companies globally. In 2015, Joe lead the sale of KBI Biopharma to JSR Corporation, a Tokyo-based multinational company. In 2016, Joe also lead the sale of kSep Systems (a KBI Biopharma cell therapy technology spinout), to Sartorius AG. Prior to KBI, Joe was a Vice President with Covance Biotechnology Services (a biopharmaceutical CDMO) from 1996 until 2002, including the sale of Covance Biotechnology Services to Akzo Nobel in 2001. Previously, Joe lead the engineering and technical services groups for a large medical device company.
